Navigation Links
Trubion Announces Presentations at April/May Investor Conferences
Date:4/24/2008

SEATTLE, April 24 /PRNewswire-FirstCall/ -- Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN), today announced that executives will present an overview of the company at two upcoming investor conferences in April and May:
-- April 30: Morgan Stanley Global Healthcare Unplugged Conference at The

Ritz-Carlton, 455 Grand Bay Drive in Key Biscayne, FL. Dr. Peter

Thompson, president, CEO and chairman, is scheduled to present at

9:50 a.m. EDT. The presentation will be available via audio Webcast at

http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=TRBN&item_id=18.

-- May 13: Bank of America 2008 Health Care Conference at the Four

Seasons, 3960 Las Vegas Blvd S in Las Vegas, NV. Michelle Burris,

senior vice president and chief financial officer, is scheduled to

present at 1:20 p.m. PDT. The presentation will be available via audio

Webcast at

http://www.veracast.com/webcasts/bas/healthcare08/id62101185.cfm.

About Trubion

Trubion is a biopharmaceutical company that is creating a pipeline of novel protein therapeutic product candidates to treat autoimmune and inflammatory diseases and cancer. The company's mission is to develop a variety of first-in-class and best-in-class product candidates, customized for optimal safety, efficacy, and convenience that it believes may offer improved patient experiences. Trubion's current product candidates are novel single-chain protein, or SMIP(TM), therapeutics, and are designed using its custom drug assembly technology. Trubion's product pipeline includes CD20-directed candidates such as TRU-015 and SBI-087 for autoimmune and inflammatory diseases developed under the company's Wyeth collaboration. Trubion's proprietary product candidate, TRU-016, is a novel CD37-targeted therapy for the treatment of B-cell malignancies currently in Phase 1/2 clinical evaluation. In addition to Trubion's current product candidates, the company is also developing additional alliance and proprietary product candidates that build on its product development experience. More information is available in the investors section of Trubion's website: investors.trubion.com.

For more information, contact:

Trubion Pharmaceuticals, Inc.

Jim DeNike

Senior Director, Corporate Communications

206-838-0500

jdenike@trubion.com

Waggener Edstrom Worldwide Healthcare

Amy Petty

Senior Account Executive

617-576-5788

amyp@waggeneredstrom.com TRBN-G


'/>"/>
SOURCE Trubion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Trubion Pharmaceuticals Inc. Reports Fourth-Quarter and Year-Ended 2007 Financial Results and Provides 2008 Financial Outlook
2. Trubion Pharmaceuticals to Present at the Lazard Capital Markets Healthcare Investor Conference
3. Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2007 Financial Results
4. Trubion Pharmaceuticals Announces Upcoming Presentations at American College of Rheumatology Annual Scientific Meeting
5. Trubion Pharmaceuticals to Present at Upcoming Investor Conferences
6. deCODE genetics Announces Webcast of Conference Call to Discuss First Quarter 2008 Financial Results
7. Abbott Announces Labs Are Vital(TM) Facebook Scholarship Contest Winners
8. Environmental Tectonics Corporations BioMedical Division Announces Sale of Two Hyperbaric Chambers
9. Inverness Medical Innovations Announces First Quarter 2008 Results
10. Aida Pharmaceuticals, Inc. Announces Completion of Research Institute Acquisition
11. Sangamo BioSciences Announces First Quarter Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/11/2017)... 11, 2017  Market researcher Kalorama Information ... article regarding the telemedicine market.  The telemedicine ... Information.  The article, "Heart and Asthma ...  used information from Kalorama Information,s Remote Patient ... Market  (Sleep, Diabetes, Vital Signs /EKG ...
(Date:8/11/2017)... ... ... Algenist continues to disrupt the skincare industry with today’s debut of GENIUS Liquid ... the key structural element skin needs to maintain its youthful appearance and Algenist is ... First to market with proprietary collagen water active , Active ...
(Date:8/10/2017)... ... August 09, 2017 , ... As a full-service marketing ... ideal customers with the right message. Their effective, cutting-edge inbound marketing strategies are ... realize how crucial the agriculture industry is,” said David Phelps, chief marketing officer ...
(Date:8/10/2017)... ... August 09, 2017 , ... ... in the clinic is here. The team at Capricor Therapeutics, Inc. utilized a ... for clinical studies. , Dr. Travis Antes, head of analytical development at ...
Breaking Biology Technology:
(Date:6/30/2017)... Today, American Trucking Associations announced Seeing ... and eye tracking software, became the newest member ... "Artificial intelligence and advanced sensing algorithms ... driver,s attentiveness levels while on the road.  Drivers ... fatigue and prevent potential accidents, which could lead ...
(Date:5/23/2017)... , May 23, 2017  Hunova, the first robotic gym for the ... been officially launched in Genoa, Italy . The first ... and the USA . The technology was developed ... market by the IIT spin-off Movendo Technology thanks to a 10 million ... News Release, please click: ...
(Date:5/6/2017)... , May 5, 2017 RAM ... announced a new breakthrough in biometric authentication based ... quantum mechanical properties to perform biometric authentication. These new ... semiconductor material created by Ram Group and its ... entertainment, transportation, supply chains and security. Ram Group ...
Breaking Biology News(10 mins):